Matthew McManus

Matthew McManus

President, Diagnostics and Spatial BiologyatBIO-TECHNE· In proxies 2022–2025

Pay in FY2025BIO-TECHNE stock -28.2% the same year

Matthew McManus was paid $2.8M in FY2025 (Jun). BIO-TECHNE stock fell 28.2% that year.

Pay$100 in the stock at the end of FY21 → $52
Pay is from the Summary Compensation Table of each BIO-TECHNE proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. BIO-TECHNEPublic company · 4 yr
    • President, Diagnostics and Spatial Biology2022 – Present · 4 yrStock in role -34%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?